Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation.

Radiat Oncol · 2022 · PMC8996402 · PMID 35410422

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The lower dose of 2 nM ganetespib did not demonstrate such a clear trend 8 h, 24 h, and 48 h after irradiation and only marginally altered the fraction of cells in S/G2/M phase.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.